Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tzu-Hsiu Chen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Life Sciences|October 22, 2013
Luteolin attenuates TGF-β1-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathwayKun-Chieh Chen, Chiu-Yuan Chen, Chih-Ru Lin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 14, 2017
Antcin-H Isolated from <i>Antrodia cinnamomea</i> Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-<i>β</i>/c-Fos-MMP-7 PathwaysKun-Yuan Chiu, Tzu-Hsiu Chen, Chi-Luan Wen, et al.
Plos Medicine|September 16, 2024
Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR MutantsHeidi Greulich, Tzu-Hsiu Chen, Whei Feng, et al.
Plos Medicine|September 29, 2005
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutantsHeidi Greulich, Tzu-Hsiu Chen, Whei Feng, et al.
Cancer Research|May 6, 2004
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arraysXiaojun Zhao, Cheng Li, J Guillermo Paez, et al.
Cancer Biology & Therapy|May 15, 2007
Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitorsYuki Yuza, Karen A Glatt, Jingrui Jiang, et al.
Cancer Research|January 28, 2010
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutationMartin L Sos, Haridas B Rode, Stefanie Heynck, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2008
Drug-sensitive FGFR2 mutations in endometrial carcinomaAmit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2Heidi Greulich, Bethany Kaplan, Philipp Mertins, et al.
Nature Medicine|June 27, 2006
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencingRoman K Thomas, Elizabeth Nickerson, Jan F Simons, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Life Sciences|October 22, 2013
Luteolin attenuates TGF-β1-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathwayKun-Chieh Chen, Chiu-Yuan Chen, Chih-Ru Lin, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 14, 2017
Antcin-H Isolated from <i>Antrodia cinnamomea</i> Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-<i>β</i>/c-Fos-MMP-7 PathwaysKun-Yuan Chiu, Tzu-Hsiu Chen, Chi-Luan Wen, et al.
Plos Medicine|September 16, 2024
Correction: Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR MutantsHeidi Greulich, Tzu-Hsiu Chen, Whei Feng, et al.
Plos Medicine|September 29, 2005
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutantsHeidi Greulich, Tzu-Hsiu Chen, Whei Feng, et al.
Cancer Research|May 6, 2004
An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arraysXiaojun Zhao, Cheng Li, J Guillermo Paez, et al.
Cancer Biology & Therapy|May 15, 2007
Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitorsYuki Yuza, Karen A Glatt, Jingrui Jiang, et al.
Cancer Research|January 28, 2010
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutationMartin L Sos, Haridas B Rode, Stefanie Heynck, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2008
Drug-sensitive FGFR2 mutations in endometrial carcinomaAmit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2Heidi Greulich, Bethany Kaplan, Philipp Mertins, et al.
Nature Medicine|June 27, 2006
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencingRoman K Thomas, Elizabeth Nickerson, Jan F Simons, et al.
Pageof 3